Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens

被引：24

作者：

Bonnet, F ^{[1
]}

Savès, M

Droz, C

Peuchant, E

Chêne, G

Beylot, J

Morlat, P

机构：

[1] Hop St Andre, Serv Med Interne & Malad Infect, Bordeaux, France

[2] Univ Victor Segalen, INSERM, U330, Bordeaux, France

[3] Hop St Andre, Biochim Lab, Bordeaux, France

来源：

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2000年 / 25卷 / 02期

关键词：

D O I：

10.1097/00126334-200010010-00017

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：199 / 200

页数：2

共 5 条

[1]

Behrens G, 1998, LANCET, V351, P1958, DOI 10.1016/S0140-6736(98)26026-0

[2] Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].

Carr, A ;

Samaras, K ;

Thorisdottir, A ;

Kaufmann, GR ;

Chisholm, DJ ;

Cooper, DA .

LANCET, 1999, 353 (9170) :2093-2099

[3] LIPIDS, LIPOPROTEINS, TRIGLYCERIDE CLEARANCE, AND CYTOKINES IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].

GRUNFELD, C ;

PANG, MY ;

DOERRLER, W ;

SHIGENAGA, JK ;

JENSEN, P ;

FEINGOLD, KR .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) :1045-1052

[4] Severe premature coronary artery disease with protease inhibitors [J].

Henry, K ;

Melroe, H ;

Huebsch, J ;

Hermundson, J ;

Levine, C ;

Swensen, L ;

Daley, J .

LANCET, 1998, 351 (9112) :1328-1328

[5] Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors [J].

Périard, D ;

Telenti, A ;

Sudre, P ;

Cheseaux, JJ ;

Halfon, P ;

Reymond, MJ ;

Marcovina, SM ;

Glauser, MP ;

Nicod, P ;

Darioli, R ;

Mooser, V .

CIRCULATION, 1999, 100 (07) :700-705

← 1 →